(-0.51%) 5 045.90 points
(-1.02%) 38 067 points
(-0.72%) 15 599 points
(1.15%) $83.76
(-3.75%) $1.591
(0.35%) $2 346.60
(0.28%) $27.42
(1.05%) $925.45
(-0.25%) $0.932
(-0.16%) $10.97
(-0.40%) $0.799
(-0.05%) $92.28
Live Chart Being Loaded With Signals
Integrated BioPharma, Inc., together with its subsidiaries, manufactures, distributes, markets, and sells vitamins, nutritional supplements, and herbal products primarily in the United States, Luxembourg, and Canada...
Stats | |
---|---|
Today's Volume | 600.00 |
Average Volume | 3 216.00 |
Market Cap | 6.47M |
EPS | $0 ( 2024-02-12 ) |
Next earnings date | ( $0 ) 2024-05-06 |
Last Dividend | $0.500 ( 2008-08-19 ) |
Next Dividend | $0 ( N/A ) |
P/E | -10.75 |
ATR14 | $0 (0.00%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-11-28 | Riva Sheppard | Buy | 150 000 | Stock Option (right to buy) |
2023-11-28 | Kay Christina | Buy | 150 000 | Stock Option (right to buy) |
2023-11-28 | Masi Dina | Buy | 150 000 | Stock Option (right to buy) |
2023-03-20 | Kay E Gerald | Sell | 150 000 | Stock Option (right to buy) |
2023-03-20 | Kay E Gerald | Sell | 100 000 | Stock Option (right to buy) |
INSIDER POWER |
---|
84.12 |
Last 98 transactions |
Buy: 38 374 999 | Sell: 953 334 |
Integrated BioPharma, Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Integrated BioPharma, Financials
Annual | 2023 |
Revenue: | $50.67M |
Gross Profit: | $4.06M (8.01 %) |
EPS: | $-0.00110 |
Q2 | 2024 |
Revenue: | $11.51M |
Gross Profit: | $520 000 (4.52 %) |
EPS: | $-0.0127 |
Q1 | 2024 |
Revenue: | $25.00M |
Gross Profit: | $832 000 (3.33 %) |
EPS: | $-0.00200 |
Q4 | 2023 |
Revenue: | $12.99M |
Gross Profit: | $986 000 (7.59 %) |
EPS: | $0.00130 |
Financial Reports:
No articles found.
Integrated BioPharma, Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
First Dividend | $0.500 | 2008-08-19 |
Last Dividend | $0.500 | 2008-08-19 |
Next Dividend | $0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 1 | -- |
Total Paid Out | $0.500 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 0.59 | -- |
Div. Sustainability Score | 2.86 | |
Div.Growth Potential Score | 0.991 | |
Div. Directional Score | 1.928 | -- |
Year | Amount | Yield |
---|
The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
PKKW | Ex Dividend Junior | 2023-09-07 | Semi-Annually | 0 | 0.00% | |
HRNNF | Ex Dividend Knight | 2023-09-12 | Quarterly | 0 | 0.00% | |
FMBM | Ex Dividend Knight | 2023-08-11 | Quarterly | 0 | 0.00% | |
CPTP | Ex Dividend Knight | 2023-08-10 | Quarterly | 0 | 0.00% | |
TNCAF | Ex Dividend Junior | 2023-08-30 | Quarterly | 0 | 0.00% | |
RSKIA | Ex Dividend Knight | 2023-09-28 | Annually | 0 | 0.00% | |
NUVR | Ex Dividend Junior | 2023-06-02 | Quarterly | 0 | 0.00% | |
FULO | Ex Dividend Knight | 2023-08-30 | Quarterly | 0 | 0.00% | |
EMYB | Ex Dividend Knight | 2023-06-29 | Annually | 0 | 0.00% | |
WCRS | Ex Dividend Junior | 2023-08-21 | Quarterly | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | -0.00615 | 1.500 | -0.123 | -0.185 | [0 - 0.5] |
returnOnAssetsTTM | -0.0150 | 1.200 | -0.499 | -0.599 | [0 - 0.3] |
returnOnEquityTTM | -0.0205 | 1.500 | -1.339 | -2.01 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 2.93 | 0.800 | 0.372 | 0.298 | [1 - 3] |
quickRatioTTM | 0.765 | 0.800 | -0.203 | -0.162 | [0.8 - 2.5] |
cashRatioTTM | 0.125 | 1.500 | -0.414 | -0.621 | [0.2 - 2] |
debtRatioTTM | 0.0884 | -1.500 | 8.53 | -10.00 | [0 - 0.6] |
interestCoverageTTM | -27.32 | 1.000 | -10.00 | -10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 0.00942 | 2.00 | 10.00 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.00829 | 2.00 | 10.00 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.122 | -1.500 | 9.51 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.0535 | 1.000 | -2.44 | -2.44 | [0.2 - 0.8] |
operatingProfitMarginTTM | -0.0109 | 1.000 | -2.22 | -2.22 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.125 | 1.000 | -0.419 | -0.419 | [0.2 - 2] |
assetTurnoverTTM | 2.43 | 0.800 | 10.00 | 8.00 | [0.5 - 2] |
Total Score | 2.86 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -16.81 | 1.000 | -1.799 | 0 | [1 - 100] |
returnOnEquityTTM | -0.0205 | 2.50 | -0.861 | -2.01 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.00829 | 2.00 | 10.00 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 0.00942 | 2.00 | 10.00 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 0.125 | 1.500 | -2.50 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.00453 | 1.000 | -2.39 | 0 | [0.1 - 0.5] |
Total Score | 0.991 |
Integrated BioPharma,
Integrated BioPharma, Inc., together with its subsidiaries, manufactures, distributes, markets, and sells vitamins, nutritional supplements, and herbal products primarily in the United States, Luxembourg, and Canada. It operates through Contract Manufacturing and Other Nutraceutical Businesses segments. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized healthcare providers. The Other Nutraceutical Businesses segment distributes healthful nutritional products for sale through mass market, grocery, drug, and vitamin retailers under the Peaceful Sleep and Wheatgrass brands, as well as other branded proprietary nutraceutical products. This segment also sells private label vitamin and nutritional supplement products through the Internet; provides warehousing and fulfilment services; and distributes fine natural botanicals, including multi minerals, as well as raw materials. The company was formerly known as Integrated Health Technologies, Inc. Integrated BioPharma, Inc. was incorporated in 1980 and is based in Hillside, New Jersey.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators